Autres langues Anagenics Limited

Actions

Marché Fermé - Australian S.E. Autres places de cotation 08:10:11 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,009 ^AUD	0,00 %		0,00 %	-52,63 %

08/03	Anagenics nomme un PDG	MT
26/02	Anagenics Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Anagenics Appoints CEO	08/03
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Anagenics Completes Placement to Raise AU$1.3 Million	07/02
Anagenics Grows Fiscal H1 Revenue	31/01
Anagenics Acquires Face Medi Group	02/10/23
Anagenics Limited Announces Board Executive Changes	02/10/23
Anagenics Limited completed the acquisition of Face MediGroup.	02/10/23
Anagenics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
Anagenics Limited agreed to acquire Face MediGroup for AUD 1.3 million.	22/08/23
Anagenics Appoints CEO/Managing Director	29/03/23
Anagenics Limited Appoints Scott Greasley as Managing Director, Effective from 1 April 2023	29/03/23
Anagenics Limited Announces CEO Changes	29/03/23
Anagenics Raises Funds from Institutional Entitlement Offer	16/02/23
Anagenics Raising AU$3.2 Million Via Entitlement Offer	14/02/23
Anagenics Limited Appoints Karen Matthews as Non-Executive Director	13/02/23
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	13/02/23
Anagenics Limited acquired Uspa Global Pty. Ltd. from BWX Limited.	09/12/22
Anagenics : FY2022 Annual Report	05/12/22
Anagenics Approves the Election of Mr. Alexander Beard as A Director	29/11/22
Anagenics Limited Announces Resignation of Dennis Eck as Director	17/10/22

Aucun résultat pour cette recherche